{
    "title": "FDA lays out proposal for naming lower-cost biotech drugs",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3213040/FDA-lays-naming-rules-lower-cost-biotech-drugs.html",
    "date": "2015-08-27",
    "keywords": [
        "biotech",
        "drug",
        "fda",
        "proposal",
        "market",
        "health",
        "industry",
        "agency",
        "fourletter",
        "code",
        "gmt",
        "august",
        "thursday",
        "care",
        "system",
        "fdas",
        "year",
        "percent",
        "biologic",
        "version",
        "safety",
        "novartis",
        "amgen",
        "press",
        "email",
        "washington",
        "food",
        "administration",
        "step",
        "class",
        "living",
        "competition",
        "term",
        "ingredient",
        "productsunder",
        "example",
        "drugcznm",
        "meaning",
        "originalsthe",
        "association",
        "statement",
        "plan",
        "access",
        "group",
        "teva",
        "sandoz",
        "fact",
        "referencea",
        "factor",
        "brandname",
        "biosimilar",
        "drugsbut",
        "drugmaker",
        "designation",
        "interchangeability",
        "input",
        "question",
        "week",
        "neupogen",
        "blockbuster",
        "blood",
        "cancer",
        "march",
        "patent",
        "litigation",
        "novartisamgen",
        "court",
        "petition",
        "aspect",
        "case",
        "europe",
        "medicines",
        "part",
        "consulting",
        "firm"
    ],
    "category": [
        "wires",
        "ap"
    ]
}